ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Pharma Stock Roundup: Teva Announces Major Job Cuts, Lilly Provides 2018 Outlook
Article By: Arpita Dutt
Friday, December 15, 2017 11:07 AM EST
Key announcements this week were Teva Pharmaceutical Industries Ltd.’s restructuring plan and Eli Lilly and Company’s 2018 outlook.
In this article: TEVA, LLY, RHHBY, BMY, MRK, SNY, GSK
Read
Sluggish Biotech Stocks: Five Underlying Factors Plus A Sector Shift?
Article By: Rod Raynovich
Thursday, November 30, 2017 5:01 PM EST
Both the biotech and healthcare sectors have been weak since the mid-October earnings release causing concerns about top line growth. Today the biotech sector tried to rally but with Nasdaq down they lost traction and were off their daily highs.
In this article: IBB, XLK Also: BITCOMP, AMZN, GOOG, NFLX, NVDA, FB, SMH, XLV, GILD, IWM, CELG, RHHBY, FBIOX
Read
E Rating Global Investing
Article By: Vivian Lewis
Wednesday, November 29, 2017 5:41 PM EST
Today we have an annual report at a funny time of the year from Canada and news from India to Singapore, from Spain to the USA, from Colombia to Britain, from Chile to Israel, and plenty of spots in between.
In this article: ALV, BBVA, BIP, BNS, BUD, CX, EC, GNC, IIF, MFD, NVO, SLB, SAN, VALE, VOD, BAESY, EONGY, NPSNY, RHHBY, TCEHY, TRYIY, ALKS, SHPG, TEVA, CUBA, PDI, AIVTF
Read
FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data
Article By: Arpita Dutt
Friday, November 24, 2017 1:53 PM EST
Pipeline and regulatory updates were the focus this week with the FDA approving the first two-drug HIV treatment in the United States and the European Commission granting approval to Johnson & Johnson’s Tremfya.
In this article: AZN, BMY, MRK, RHHBY, PFE, GSK, JNJ, NVS
Read
Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod
Article By: Arpita Dutt
Friday, November 10, 2017 3:13 PM EST
Earnings remained in focus this week with companies like AstraZeneca reporting third-quarter results. Meanwhile, companies like Roche and Merck & Co., Inc. were in the news due to regulatory updates.
In this article: AZN, GSK, MRK Also: JNJ, LLY, SNY, RHHBY
Read

PARTNER HEADLINES

Latest Tweets for $RHHBY

No tweets yet!